COVID-19 vaccine success enables a bolder vision for mRNA cancer vaccines, by Ugur Sahin,CEO,BioNTech
Ugur Sahin, an oncologist and mRNA pioneer, discusses development plans for cancer vaccines, mRNA-encoded proteins and more for his firm’s. When Ugur Sahin got to know in January 2020 about the emergent threat of SARS-CoV-2, he immediately started thinking about how BioNTech’s mRNA platform could be used to rapidly deliver a vaccine. His company and … Read more